BURNING ROCK BIOTECH LTD-ADR (BNR) Fundamental Analysis & Valuation

NASDAQ:BNR • US12233L2060

Current stock price

16.095 USD
-0.91 (-5.32%)
Last:

This BNR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BNR Profitability Analysis

1.1 Basic Checks

  • BNR had negative earnings in the past year.
  • BNR had negative earnings in each of the past 5 years.
  • In the past 5 years BNR always reported negative operating cash flow.
BNR Yearly Net Income VS EBIT VS OCF VS FCFBNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M -800M

1.2 Ratios

  • BNR has a Return On Assets of -6.75%. This is amongst the best in the industry. BNR outperforms 83.30% of its industry peers.
  • BNR's Return On Equity of -10.34% is amongst the best of the industry. BNR outperforms 85.44% of its industry peers.
Industry RankSector Rank
ROA -6.75%
ROE -10.34%
ROIC N/A
ROA(3y)-36.25%
ROA(5y)-40.98%
ROE(3y)-51.7%
ROE(5y)-56.42%
ROIC(3y)N/A
ROIC(5y)N/A
BNR Yearly ROA, ROE, ROICBNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • BNR has a better Gross Margin (74.67%) than 81.94% of its industry peers.
  • BNR's Gross Margin has been stable in the last couple of years.
  • BNR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.44%
GM growth 5Y0.45%
BNR Yearly Profit, Operating, Gross MarginsBNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BNR Health Analysis

2.1 Basic Checks

  • BNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BNR has been increased compared to 1 year ago.
  • The number of shares outstanding for BNR has been increased compared to 5 years ago.
  • BNR has a worse debt/assets ratio than last year.
BNR Yearly Shares OutstandingBNR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BNR Yearly Total Debt VS Total AssetsBNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • BNR has an Altman-Z score of -3.60. This is a bad value and indicates that BNR is not financially healthy and even has some risk of bankruptcy.
  • BNR has a Altman-Z score of -3.60. This is comparable to the rest of the industry: BNR outperforms 42.33% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that BNR is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.00, BNR perfoms like the industry average, outperforming 47.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.6
ROIC/WACCN/A
WACC7.99%
BNR Yearly LT Debt VS Equity VS FCFBNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • BNR has a Current Ratio of 2.99. This indicates that BNR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.99, BNR is doing worse than 62.91% of the companies in the same industry.
  • A Quick Ratio of 2.76 indicates that BNR has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.76, BNR is doing worse than 63.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.99
Quick Ratio 2.76
BNR Yearly Current Assets VS Current LiabilitesBNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BNR Growth Analysis

3.1 Past

  • BNR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.66%, which is quite impressive.
  • Looking at the last year, BNR shows a small growth in Revenue. The Revenue has grown by 4.60% in the last year.
  • BNR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.65% yearly.
EPS 1Y (TTM)84.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.32%
Revenue 1Y (TTM)4.6%
Revenue growth 3Y-1.42%
Revenue growth 5Y4.65%
Sales Q2Q%0.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 9.28% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.32%
Revenue Next 2Y3.7%
Revenue Next 3Y7.02%
Revenue Next 5Y9.28%

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BNR Yearly Revenue VS EstimatesBNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
BNR Yearly EPS VS EstimatesBNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

0

4. BNR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BNR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNR Price Earnings VS Forward Price EarningsBNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BNR Per share dataBNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BNR Dividend Analysis

5.1 Amount

  • BNR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BNR Fundamentals: All Metrics, Ratios and Statistics

BURNING ROCK BIOTECH LTD-ADR

NASDAQ:BNR (5/1/2026, 10:32:03 AM)

16.095

-0.91 (-5.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-23
Earnings (Next)06-04
Inst Owners24.33%
Inst Owner Change-1.84%
Ins OwnersN/A
Ins Owner Change1.68%
Market Cap165.11M
Revenue(TTM)539.57M
Net Income(TTM)-55.35M
Analysts80
Price TargetN/A
Short Float %7.43%
Short Ratio1.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.11
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.7
BVpS7.64
TBVpS7.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.75%
ROE -10.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.67%
FCFM N/A
ROA(3y)-36.25%
ROA(5y)-40.98%
ROE(3y)-51.7%
ROE(5y)-56.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.44%
GM growth 5Y0.45%
F-ScoreN/A
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.99
Quick Ratio 2.76
Altman-Z -3.6
F-ScoreN/A
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.6%
Revenue growth 3Y-1.42%
Revenue growth 5Y4.65%
Sales Q2Q%0.23%
Revenue Next Year-6.32%
Revenue Next 2Y3.7%
Revenue Next 3Y7.02%
Revenue Next 5Y9.28%
EBIT growth 1Y82.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BURNING ROCK BIOTECH LTD-ADR / BNR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BURNING ROCK BIOTECH LTD-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to BNR.


Can you provide the valuation status for BURNING ROCK BIOTECH LTD-ADR?

ChartMill assigns a valuation rating of 0 / 10 to BURNING ROCK BIOTECH LTD-ADR (BNR). This can be considered as Overvalued.


How profitable is BURNING ROCK BIOTECH LTD-ADR (BNR) stock?

BURNING ROCK BIOTECH LTD-ADR (BNR) has a profitability rating of 3 / 10.